The present invention relates to an antitumor composition containing: a GM-CSF gene; and an shRNA inhibiting TGF-β2 expression, and an antitumor composition containing: a GM-CSF gene; a decorin gene; an shRNA inhibiting TGF-β2 expression; and an shRNA inhibiting FoxP3 expression.
展开▼